The RIONI study rationale and design: Validation of the first stored electrograms transmitted via home monitoring in patients with implantable defibrillators

Europace

Volumn 8, Issue 4, 2006, Pages 288-292

  Perings, Christian ^a,h   Klein, G ^b   Toft, E ^c,d   Moro, C ^e   Klug, D ^f   Bocker D ^g   Trappe, H J ^a   Korte, T ^b   Bauer, W ^h   Broadhurst, P ^h   Cripps, T ^h   Duckeck, W ^h   Geelen, P ^h   Geller, J C ^h   Gonska, B D ^h   Hartmann, A ^h   Hintringer, F ^h   Hoffmann, E ^h   James, M ^h   Mason, M ^h   Mentz, G ^h   Mewis, C ^h   Nagele H ^h   Paul, V ^h   Rouwen, A J ^h   Sadowski, R ^h   Schuchert, A ^h   Schwab, J O ^h   Schwacke, H ^h   Tiroke, A ^h   Wacker, C ^h   Weiss C ^h   Wende, C ^h   more..

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c AALBORG UNIVERSITY   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e HOSPITAL RAMÓN Y CAJAL   (Spain)

^f UNIV LILLE   (France)

^g UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^h NONE

Author keywords

Home monitoring; Implantable defibrillator; Stored intracardiac electrogram

Indexed keywords

ARTICLE; CLASSIFICATION; CLINICAL TRIAL; DATA ANALYSIS; DATA STORAGE DEVICE; DECISION MAKING; DEFIBRILLATOR; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY MONITORING; EXPERIMENTAL DESIGN; HOLTER MONITORING; HOME MONITORING; HUMAN; INFORMATION PROCESSING; INTERMETHOD COMPARISON; MEDICAL EXPERT; ONLINE MONITORING; PRIORITY JOURNAL; RELIABILITY; VALIDATION STUDY;

EID: 33745213199     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eul009     Document Type: Article

References (19)

1. Winkle RA, Mead RH, Ruder MA, Gaudiani VA, Smith NA, Buch WS et al. Long-term-outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989;13:1353-61.
2. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83.
3. Moss AJ, Hall WJ, Cannom DS et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-40.
4. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
5. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
6. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49.
7. Korte T, Jung W, Ostermann G, Wolpert C, Spehl S, Esmailzadeh B et al. Hospital readmission after transvenous cardioverter/defibrillator implantation: A single centre study. Eur Heart J 2000;21:1186-96.
8. Marchlinski FE, Callans DJ, Gottlieb CD, Schwatzman D, Preminger M. Benefits and lessons learned from stored electrogram information in implantable defibrillators. J Cardiovasc Electrophysiol 1995;6:832-51.
9. Auricchio A, Hartung W, Geller C, Klein H. Clinical relevance of stored electrograms for implantable cardioverter-defibrillators (ICD) troubleshooting and understanding of mechanisms for ventricular tachyarrhythmias. Am J Cardiol 1996;78:33-41.
10. Theuns DA, Res JC, Jordaens LJ. Feasibility of home monitoring in ICD therapy: Future perspectives. Europace 2003;5:139-42.
11. Bänsch D, Steffgen F, Grönefeld G, Wolpert C, Böcker D, Mletzko RU et al. The 1+1 trail: A prospective trial of a dual- versus a single-chamber implantable defibrillator in patients with slow ventricular tachycardias. Circulation 2004;110:1022-9.
12. Dorian P, Philippon, F, Thibault B, Kimber S, Sterns L, Greene M et al., ASTRID Investigators. Randomized controlled study of the detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual chamber implantable cardioverter-defibrillator. Heart Rhythm 2004;1:540-7.
13. Theuns DA, Klootwijk AP, Goedhart DM, Jordaens LJ. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms. J Am Coll Cardiol 2004;44:2362-7.
14. Glikson M, Swerdlow CD, Gurevitz OT, Daoud E, Shivkumar K, Wilkoff B et al. Optimal combination of discriminators for differentiating ventricular from supraventricular tachycardia by dual-chamber defibrillators. J Cardiovasc Electrophysiol 2005;16:732-9.
15. Wolpert C, Kuschyk J, Aramin N, Spehl S, Streitner F, Suselbeck T et al. Incidence and electrophysiological characteristics of spontaneous ventricular tachyarrhythmias in high risk coronary patients and prophylactic implantation of a defibrillator. Heart 2004;90:667-71.
16. Schoenfeld MH, Compton SJ, Mead RH, Weiss DN, Sherfesee L et al. Remote monitoring of implantable cardioverter defibrillators: A prospective analysis. Pacing Clin Electrophysiol 2004;27:757-63.
17. Winter SL, Packer DL, Marchlinski FE et al. Consensus statement on indications, guidelines for use, and recommendations for follow-up of implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2001;24:262-9.
18. McGrory-Usset ME, Stanton MS. Use of implantable cardioverter defibrillator (ICD) Therapy and ICD guidelines around the world. In: Ovyshcher IE, ed. New Development in Cardiac Pacing and Electrophysiology. Armonk, NY: Futura Publishing Company Inc.; 2002. p81-90.
19. Frye WB. Cardiology workforce: There's already a shortage, and its getting worse! J Am Coll Cardiol 2002;39:2077-9.